We hypothesized that the longevity‐associated FOXO3 genotype would be associated with a sizable risk reduction for mortality and with one or more major age‐associated clinical causes of death, such as coronary heart disease (CHD), cancer, and stroke. This evidence concerns the gene FOXO3 and cancer.